Literature DB >> 20213196

Novel strategy for treatment of pulmonary arterial hypertension: enhancement of apoptosis.

Jing-bin Huang1, Ying-long Liu, Pei-wu Sun, Xiao-dong Lv, Kong Bo, Xiang-ming Fan.   

Abstract

Advanced pulmonary arterial hypertension is characterized by extensive vascular remodeling that is usually resistant to vasodilator therapy. As the major component of the vascular media, decreased apoptosis of pulmonary arterial smooth muscle cell (PASMC) plays key roles during pulmonary vascular remodeling. Recent studies showed that enhancement of apoptosis of PASMC can reverse pulmonary vascular remodeling and severe pulmonary arterial hypertension. Enhancement of apoptosis of PASMC is becoming a novel strategy to reverse severe pulmonary arterial hypertension. This review analyzes some potential strategies to reverse pulmonary vascular remodeling.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20213196     DOI: 10.1007/s00408-010-9233-8

Source DB:  PubMed          Journal:  Lung        ISSN: 0341-2040            Impact factor:   2.584


  96 in total

1.  Effects of fasudil in acute ischemic stroke: results of a prospective placebo-controlled double-blind trial.

Authors:  Masato Shibuya; Shunsaku Hirai; Minoru Seto; Shin-ichi Satoh; Eiichi Ohtomo
Journal:  J Neurol Sci       Date:  2005-07-11       Impact factor: 3.181

2.  New developments in lipid-lowering therapy: the role of inhibitors of hydroxymethylglutaryl-coenzyme A reductase.

Authors:  J A Tobert
Journal:  Circulation       Date:  1987-09       Impact factor: 29.690

3.  Rosiglitazone attenuates hypoxia-induced pulmonary arterial remodeling.

Authors:  Joseph T Crossno; Chrystelle V Garat; Jane E B Reusch; Kenneth G Morris; Edward C Dempsey; Ivan F McMurtry; Kurt R Stenmark; Dwight J Klemm
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2006-12-22       Impact factor: 5.464

4.  Gene therapy targeting survivin selectively induces pulmonary vascular apoptosis and reverses pulmonary arterial hypertension.

Authors:  M Sean McMurtry; Stephen L Archer; Dario C Altieri; Sebastien Bonnet; Alois Haromy; Gwyneth Harry; Sandra Bonnet; Lakshmi Puttagunta; Evangelos D Michelakis
Journal:  J Clin Invest       Date:  2005-06       Impact factor: 14.808

5.  3-Hydroxy-3-methylglutaryl-CoA reductase inhibitors attenuate vascular smooth muscle proliferation by preventing rho GTPase-induced down-regulation of p27(Kip1).

Authors:  U Laufs; D Marra; K Node; J K Liao
Journal:  J Biol Chem       Date:  1999-07-30       Impact factor: 5.157

6.  Distinct functions of nuclear and cytoplasmic calcium in the control of gene expression.

Authors:  G E Hardingham; S Chawla; C M Johnson; H Bading
Journal:  Nature       Date:  1997-01-16       Impact factor: 49.962

7.  Rho kinase-mediated vasoconstriction is important in severe occlusive pulmonary arterial hypertension in rats.

Authors:  Masahiko Oka; Noriyuki Homma; Laimute Taraseviciene-Stewart; Kenneth G Morris; Donatas Kraskauskas; Nana Burns; Norbert F Voelkel; Ivan F McMurtry
Journal:  Circ Res       Date:  2007-03-01       Impact factor: 17.367

8.  Activation of apoptosis signal-regulating kinase 1 in injured artery and its critical role in neointimal hyperplasia.

Authors:  Yasukatsu Izumi; Shokei Kim; Minoru Yoshiyama; Yasuhiro Izumiya; Kaoru Yoshida; Atsushi Matsuzawa; Hidenori Koyama; Yoshiki Nishizawa; Hidenori Ichijo; Junichi Yoshikawa; Hiroshi Iwao
Journal:  Circulation       Date:  2003-11-24       Impact factor: 29.690

Review 9.  Potassium channels in the regulation of pulmonary artery smooth muscle cell proliferation and apoptosis: pharmacotherapeutic implications.

Authors:  E D Burg; C V Remillard; J X-J Yuan
Journal:  Br J Pharmacol       Date:  2007-12-17       Impact factor: 8.739

10.  Rho kinase-induced nuclear translocation of ERK1/ERK2 in smooth muscle cell mitogenesis caused by serotonin.

Authors:  Yinglin Liu; Yuichiro J Suzuki; Regina M Day; Barry L Fanburg
Journal:  Circ Res       Date:  2004-08-05       Impact factor: 17.367

View more
  8 in total

Review 1.  Epigenetics: novel mechanism of pulmonary hypertension.

Authors:  Jing-bin Huang; Jian Liang; Xiao-fang Zhao; Wen-sen Wu; Fu Zhang
Journal:  Lung       Date:  2013-09-20       Impact factor: 2.584

2.  MicroRNA-mediated downregulation of K+ channels in pulmonary arterial hypertension.

Authors:  Aleksandra Babicheva; Ramon J Ayon; Tengteng Zhao; Jose F Ek Vitorin; Nicole M Pohl; Aya Yamamura; Hisao Yamamura; Brooke A Quinton; Manqing Ba; Linda Wu; Keeley S Ravellette; Shamin Rahimi; Francesca Balistrieri; Angela Harrington; Rebecca R Vanderpool; Patricia A Thistlethwaite; Ayako Makino; Jason X-J Yuan
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-09-25       Impact factor: 5.464

3.  Inhibition of MRP4 prevents and reverses pulmonary hypertension in mice.

Authors:  Yannis Hara; Yassine Sassi; Christelle Guibert; Natacha Gambaryan; Peter Dorfmüller; Saadia Eddahibi; Anne-Marie Lompré; Marc Humbert; Jean-Sébastien Hulot
Journal:  J Clin Invest       Date:  2011-06-13       Impact factor: 14.808

4.  Clinical comparative analysis of histidine-tryptophan-ketoglutarate solution and St. Thomas crystalloid cardioplegia: A 12-year study from a single institution.

Authors:  Ying-Zhong Lin; Jing-Bin Huang; Xiang-Wei Li; Xian-Ming Tang; Wei-Jun Lu; Zhao-Ke Wen; Jian Liang; Dian-Yuan Li; Hao Wang
Journal:  Exp Ther Med       Date:  2017-07-19       Impact factor: 2.447

5.  Serum Bcl-2 values in children with pulmonary hypertension.

Authors:  Alper Akın; Dursun Alehan; Hayrettin Hakan Aykan; Süheyla Özkutlu; Sema Özer; Tevfik Karagöz
Journal:  Pediatr Cardiol       Date:  2014-11-09       Impact factor: 1.655

Review 6.  Mechanical Regulation of Apoptosis in the Cardiovascular System.

Authors:  Zachary E Goldblatt; Heather A Cirka; Kristen L Billiar
Journal:  Ann Biomed Eng       Date:  2020-11-09       Impact factor: 3.934

7.  Pleiotropic effects of statins in distal human pulmonary artery smooth muscle cells.

Authors:  Omar F Ali; Ellena J Growcott; Ghazwan S Butrous; John Wharton
Journal:  Respir Res       Date:  2011-10-14

Review 8.  Bioactivities and mechanisms of natural medicines in the management of pulmonary arterial hypertension.

Authors:  Zhijie Yu; Jun Xiao; Xiao Chen; Yi Ruan; Yang Chen; Xiaoyuan Zheng; Qiang Wang
Journal:  Chin Med       Date:  2022-01-15       Impact factor: 5.455

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.